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Reporting in Cell, Mesmin et al. (2013) show how a single molecule of oxysterol binding protein, which has a
lipid binding domain that solubilizes both sterol and PI4P, might integrate its two specificities to drive the two
lipids in opposite directions across endoplasmic reticulum-Golgi membrane contact sites.Lipid transfer proteins (LTPs) have a lipid
binding domain (LBD) that solubilizes lipid
into a hydrophobic pocket. Some LBDs
are lipid sensors, for example steroid re-
ceptors, while others are LTPs. Oxysterol
binding protein (OSBP) was discovered
over 20 years ago through its cytoplasmic
LBD, which has affinity for 25-hydroxy-
cholesterol (25HC). It was later shown
that OSBP responds to this ligand by
translocating to the Golgi apparatus
(Ridgway et al., 1992). The translocation
was interpreted to imply activation of
OSBP, but the activity was mysterious:
what does OSBP do after targeting the
Golgi, and is it a sensor or an LTP?
Three major domains in OSBP provide
clues to function: a pleckstrin homology
(PH) domain that targets the trans-Golgi
by binding phosphatidylinositol 4-phos-
phate (PI4P) and Arf1; a FFAT motif that
binds to VAMP-associated protein (VAP)
on the endoplasmic reticulum (ER); and
the LBD that is now known to bind highly
abundant cholesterol as tightly as 25HC.
These three domains of OSBP could
easily collaborate in one single function:
sterol transfer at membrane contact sites
(MCSs) between the ER and the trans-
Golgi, similar to the ceramide transfer
protein CERT, which has the same pattern
of three domains with an LBD specific
for ceramide (Hanada et al., 2003). The
analogy of CERT implying that OSBP
mediates sterol traffic at the ER-Golgi
MCS fell at two hurdles: first, yeast lack-
ing all seven OSBP homologs still appear
to have bulk sterol traffic (Georgiev et al.,
2011), and second, MCS tethering is not
involved in bulk retrograde sterol traffic
in mammalian cells (Mesmin et al., 2011).
To complicate matters further, PI4P
was surprisingly found to competedirectly for sterol binding to the LBD of
Osh4p in yeast. The mechanism for this
was explained neatly with a crystal struc-
ture of Osh4p with PI4P in the same
pocket that binds sterol (de Saint-Jean
et al., 2011). This suggested a counter-
current model in which OSBP homologs
exchange PI4P trafficking from Golgi to
ER for sterol trafficking in the other direc-
tion. The gradient of PI4P could drive its
retrograde traffic, because it is made by
PI 4-kinase-beta in the trans-Golgi and
hydrolyzed by Sac1, a PI 4-phosphatase
resident in the ER. A problem with
gradient-driven forward traffic of sterol is
that this lipid is also enriched in the Golgi
over the ER, although the concentration
of free sterol in the two bilayers may be
more equivalent, because in the trans-
Golgi it forms complexes with long-chain,
saturated lipids such as sphingomyelin
(Baumann et al., 2005) that are sorted
irreversibly into anterograde carriers
(Figure 1A). If forward sterol traffic is not
energetically favorable, it must be driven
by an external force. Mesmin et al.
(2013) now report inCell in vitro and in vivo
evidence that OSBP does indeed traffic
these both sterol and PI4P in a tightly
choreographed ballet at ER-Golgi MCSs.
Mesmin et al. (2013) make the key
finding that OSBP activity includes
removing PI4P from the trans-Golgi. By
coexpressing different forms of OSBP
together with a PI4P detector, the authors
show that OSBP reduces the levels of
Golgi PI4P. This only happens efficiently
if OSBP is tethered at the MCS by
engaging both the FFAT motif and PH
domain, so the activity requires prior
translocation to the Golgi. But tethering
by PH plus FFAT is not enough—the lipid
must also be solubilized by the LBD.Developmental Cell 27, NOverall, the activity that removes PI4P
negatively feeds back on itself, because
PI4P is needed for PH targeting and,
hence, tethering. This negative feedback
explains why overexpressed OSBP is
not found at the Golgi: its activity
constantly destroys its own ability to
translocate there. The old mystery of
Golgi translocation with micromolar
25HC is finally explained: 25HC prevents
loading by any other lipid, so while the
protein translocates to ER-Golgi con-
tacts, the activity that removes PI4P
is blocked. Thus, inactive OSBP-25HC
complexes stay tethered, unable to re-
move PI4P or undock. Another aspect of
PI4P removal by OSBP is that it needs
active Sac1. Previous findings that PI4P
accumulates in the ER in cells lacking
Sac1 support the idea that OSBP trans-
fers PI4P. However, experiments are
needed to distinguish between that and
two other plausible models whereby
OSBP mediates PI4P hydrolysis, espe-
cially because PI4P transfer is the only
option in which Sac1 hydrolysis of PI4P
would clearly provide the necessary
external driving force for 1:1 countercur-
rent sterol/PI4P traffic (Figure 1B).
To study sterol traffic, Mesmin et al.
(2013) pulsed cells from the outside with
dihydroergosterol (DHE), a fluorescent
cholesterol analog that behaves very
similarly to the real thing. Normally, DHE
is transported back to the ER, where it is
esterified for storage in lipid droplets.
However, in cells overexpressing OSBP,
much less DHE traffics to lipid droplets,
suggesting that OSBP diverts the analog
from the ER to the Golgi before it is ester-
ified. If anterograde sterol traffic is linked
to retrograde PI4P traffic, the prediction
is that OSBP can only divert DHE if itovember 25, 2013 ª2013 Elsevier Inc. 369
Figure 1. Models for Solubilization of Sterol and PI4P by OSBP at
ER-Golgi MCSs
(A) Anterograde sterol traffic to the Golgi. (B) Three ways OSBP (red) tethered
between ER (yellow) and Golgi (pink) may facilitate PI4P hydrolysis by Sac1
(blue). (i) Retrograde traffic to the ER. (ii) Presentation to Sac1 within the cyto-
plasmic gap, analogous to presentation of PI to PI-kinase by PITPs. Delivery of
this PI to the ER would make this model indistinguishable from (i). (iii) Allosteric
activation of Sac1 by OSBP-PI4P complexes (green arrow). Black arrows
show flows of lipids, which can be solubilized (labeled ‘‘sol’’). Unfavorable di-
rections of reversible lipid flows are shown as dashed. Details of tethering by
PI4P, Arf1, and VAP are not shown. Overexpressed inactive, OSBP tethering
constructs (just FFAT and PH) enlarge contacts, but a structural role for
OSBP at physiological levels cannot be deduced. Because (Bi) requires
OSBP to unload PI4P at the ER and not rebind it, only this model obviously ex-
plains a sterol/PI4P countercurrent.
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exactly what the authors
show. A further prediction
of countercurrent flow is that
removal of Golgi PI4P by
OSBP requires the sterol
gradient to be maintained
within certain limits. Mesmin
et al. (2013) find some evi-
dence for this, because
OSBP is unable to remove
Golgi PI4P in cells depleted
of cholesterol. However, a
sterol countercurrent is not
needed for PI4P traffic
in vitro, so key details of
OSBP function remain to be
determined. OSBP with a
mutated LBD that solubi-
lizes only PI4P (not sterol)
should be tested here, as
work on Osh4p has sug-
gested that this is hyperac-
tive for PI4P traffic, ratherthan being impaired by lack of counter-
current (Alfaro et al., 2011).
The discovery that the activity of OSBP
is not centered on sterol alone but in-
volves PI4P is supported by recently
solved structures of yeast Osh3p, which
binds PI4P but not sterol (Tong et al.,
2013). Also, yeast Osh6p has been
elegantly shown to transfer phosphatidyl-
serine (Maeda et al., 2013). However,370 Developmental Cell 27, November 25, 20neither Osh3p nor Osh6p has known sec-
ond lipid ligands (yet). Nevertheless,
OSBP is clearly implicated in the intracel-
lular redistribution of two lipids, so the
powerful idea of lipid countercurrents
needs more study. It may be that this
pas de deux is specifically required for
sterol traffic only into the Golgi and that
other routes use different mechanisms
(Georgiev et al., 2011).13 ª2013 Elsevier Inc.REFERENCES
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